首页> 外文期刊>Clinical and vaccine immunology: CVI >Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity
【24h】

Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity

机译:缺乏免疫原性的干扰嵌合甲病毒复制子particle-based由先前存在的antivector流感疫苗免疫力

获取原文
获取原文并翻译 | 示例
           

摘要

Antivector immunity has been recognized as a potential caveat of using virus-based vaccines. In the present study, an alphavirus-based replicon particle vaccine platform, which has demonstrated robust immunogenicity in animal models, was tested for effects of antivector immunity on immunogenicity against hemagglutinin of influenza virus as a target antigen and efficacy for protection against lethal challenge with the virus. Chimeric alphavirus-based replicon particles, comprising Venezuelan equine encephalitis virus nonstructural and Sindbis virus structural components, induced efficient protective antibody responses, which were not adversely influenced after multiple immunizations with the same vector expressing various antigens.
机译:被公认为Antivector免疫力使用virus-based疫苗的潜在的警告。在目前的研究中,一个alphavirus-based复制子粒子疫苗平台,展示了强劲的免疫原性的动物antivector模型,检测的影响免疫对血凝素免疫原性流感病毒的抗原和目标功效为防止致命的挑战与病毒。复制子粒子,由委内瑞拉马脑炎病毒非结构和辛德毕斯病毒的结构组件,诱导效率保护性抗体反应,也没有多种免疫接种后产生不利影响相同的向量表达各种抗原。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号